1-14 of 14
Hana Plonkova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Composition and Fitness of T and NK Cells in Extramedullary Myeloma Tumor Microenvironment

David Zihala, Anjana Anilkumar Sithara, Veronika Kapustova, Ondrej Venglar, Eva Radova, Lucie Broskevicova, Jan Vrana, Serafim Nenarokov, Daniel Bilek, Ludmila Muronova, Tereza Popkova, Jana Mihalyova, Hana Plonkova, Sandra Charvatova, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Michal Simicek, Tereza Sevcikova, Roman Hajek, Tomas Jelinek
Journal: Blood
Blood (2024) 144 (Supplement 1): 1887.
https://doi.org/10.1182/blood-2024-206798
Published: 2024
Journal Articles

Insights into Biological Mechanisms Responsible for Egression of Circulating Tumor Plasma Cells (CTCs) in Multiple Myeloma

Tomas Jelinek, Serafim Nenarokov, Tereza Sevcikova, Eva Radova, Ondrej Venglar, Veronika Kapustova, Lucie Broskevicova, Jan Vrana, Ludmila Muronova, Tereza Popkova, Jana Mihalyova, Hana Plonkova, Michal Simicek, Bachisio Ziccheddu, Benjamin Diamond, Francesco Maura, Ola Landgren, David Zihala, Roman Hájek
Journal: Blood
Blood (2024) 144 (Supplement 1): 3270.
https://doi.org/10.1182/blood-2024-206825
Published: 2024
Journal Articles

Predictive Value of Clonal Plasma Cells in Autografts Assessed By Next Generation Flow Cytometry on Pre-Transplant Bone Marrow MRD in Multiple Myeloma Patients

Ondrej Venglar, Eva Radova, David Zihala, Ivana Tvrda, Ludmila Muronova, Veronika Kapustova, Lucie Broskevicova, Jan Vrana, Tereza Popkova, Jana Mihalyova, Hana Plonkova, Tereza Sevcikova, Michal Kascak, Milan Navratil, Zdenek Koristek, Roman Hajek, Tomas Jelinek
Journal: Blood
Blood (2024) 144 (Supplement 1): 1962.
https://doi.org/10.1182/blood-2024-204692
Published: 2024
Journal Articles

A Multicenter Phase 2 Study Evaluating the Optimized Schedule of Belantamab Mafodotin 1.9 Mg/Kg Q8W Plus Bortezomib and Dexamethasone in Relapsed Refractory Multiple Myeloma

Tereza Popkova, Jakub Radocha, Martin Stork, Jiří Minařík, Jan Straub, Alexandra Jungova, Petr Pavlicek, Tomas Jelinek, Vladimir Maisnar, Ludek Pour, Tomas Pika, František Sedlák, Jan Soukup, Hana Plonkova, Ludmila Muronova, Viera Sandecka, Petra Krhovska, David Zihala, Roman Hajek
Journal: Blood
Blood (2024) 144 (Supplement 1): 1999.
https://doi.org/10.1182/blood-2024-211224
Published: 2024
Journal Articles

Pathogenesis of Extramedullary Multiple Myeloma: From Resistance to Identification of Novel Therapeutic Targets

Tomas Jelinek, David Zihala, Tereza Sevcikova, Veronika Kapustova, Hana Sahinbegovic, Anjana Anilkumar Sithara, Tereza Popkova, Hana Plonkova, Lucie Broskevicova, Jan Vrana, Vladimir Zidlik, Martin Havel, Zdenek Koristek, Juli R. Bago, Michal Simicek, Roman Hajek
Journal: Blood
Blood (2021) 138 (Supplement 1): 2680.
https://doi.org/10.1182/blood-2021-150876
Published: 2021
Journal Articles

Follow-up Analysis of Ixazomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Routine Clinical Practice

Jiri Minarik, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Tomas Pika, Ludek Pour, Petr Pavlicek, Lubica Harvanova, Lenka Capkova, Petra Krhovska, Katerina Machalkova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Martin Mistrik, Jaroslav Bacovsky, Vladimir Maisnar, Roman Hajek
Journal: Blood
Blood (2021) 138 (Supplement 1): 2716.
https://doi.org/10.1182/blood-2021-148836
Published: 2021
Journal Articles

Prognostic Value of PET/CT Performed Day +100 Post Autologous Stem Cell Transplantation in Multiple Myeloma: Real-World Single Center Experience

Ludmila Muronova, Martin Havel, MD PhD, Tereza Popkova, Hana Plonkova, Roman Hajek, Tomas Jelinek
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-142369
Published: 2020
Journal Articles

Identification of Molecular Mechanisms Responsible for the Development of Extramedullary Disease in Myeloma and Potential Novel Therapeutic Targets Using Transcriptomic and Exome Profiling

David Zihala, Tereza Sevcikova, Michal Simicek, Tereza Popkova, Hana Plonkova, Lucie Broskevicova, Jan Vrana, Juli R. Bago, Roman Hajek, Giovanni Stracquadanio, Tomas Jelinek
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-142300
Published: 2020
Journal Articles

Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment

Tereza Popkova, MD, Katarina Hradska, MD, Jana Mihalyova, MD, Michaela Skorupova, Tomas Jelinek, MD, Juraj Duras, MD, Zdenek Koristek, MD PhD, Milan Navratil, MD, Katerina Benkova, MD, Hana Plonkova, MD, Jana Zuchnicka, MD, Jaromir Gumulec, MD, Roman Hajek, Prof, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4757.
https://doi.org/10.1182/blood-2019-127011
Published: 2019
Journal Articles

Overall Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (RD) in RRMM Patients Treated in Routine Clinical Practice: Results from the Czech Registry of Monoclonal Gammopathies (RMG)

Jiri Minarik, MD PhD, Tomas Pika, MD PhD, Jakub Radocha, Alexandra Jungova, Jan Straub, MD, Tomas Jelinek, MD, Ludek Pour, MD, Petr Pavlicek, MD, Martin Mistrik, MD PhD, Lucie Brožová, MSc, Petra Krhovska, Katerina Machalkova, Pavel Jindra, MD PhD, Ivan Spicka, MD PhD Prof, Hana Plonkova, MD, Martin Stork, MD, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, MD, Lukáš Stejskal, MD, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, MD, Vladimir Maisnar, MD PhD MBA, Roman Hajek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3139.
https://doi.org/10.1182/blood-2019-128865
Published: 2019
Journal Articles

Treatment of Relapsed and Refractory Multiple Myeloma with Fully Oral Triplet IRD (ixazomib, lenalidomide and dexamethasone) Is Safe and with Significant Therapeutic Outcomes

Jiri Minarik, MD PhD, Petra Krhovska, Tomas Jelinek, Alexandra Jungova, Martin Mistrik, MD PhD, Tomas Pika, MD PhD, Evzen Gregora, MD, Vladimir Maisnar, MD, Jan Straub, MD, Ludek Pour, MD, Lucie Brozova, MSc, Jaroslav Bacovsky, Hana Plonkova, Pavel Jindra, MD PhD, Petr Pavlicek, MD, Jakub Radocha, MD, Ivan Spicka, MDPhDProf, Martin Stork, MD, Vlastimil Scudla, Prof, MD CSc, Roman Hajek
Journal: Blood
Blood (2018) 132 (Supplement 1): 1959.
https://doi.org/10.1182/blood-2018-99-112046
Published: 2018
Journal Articles

Bortezomib-Based Induction Treatment for Patients with Multiple Myeloma Ineligible for Autologous Stem Cell Transplantation: A Retrospective Multicenter Study in Czech Republic

Viera Sandecka, MD, Ludek Pour, Doc,MD PhD, Sabina Sevcikova, RNDr, PhD, Lucie Brozova, MSc, Jan Straub, MD, Vlastimil Scudla, Prof, MD CSc, Vladimir Maisnar, Prof, MD PhD, Petr Pavlicek, MD, Zdenek Adam, Prof, MD CSc, Marta Krejci, Prof, MD PhD, Martin Stork, MD, Tomas Jelinek, Hana Plonkova, Roman Hajek
Journal: Blood
Blood (2017) 130 (Supplement 1): 5435.
https://doi.org/10.1182/blood.V130.Suppl_1.5435.5435
Published: 2017
Journal Articles

Single Agent Daratumumab in Advanced Multiple Myeloma: Specific Healthcare Program in the Czech Republic

Jiri Minarik, MD PhD, Ludek Pour, MD PhD, Vladimir Maisnar, Prof, MD PhD, Ivan Spicka, MDPhD, Alexandra Jungova, MD, Hana Plonkova, Lucie Brozova, MSc, Petra Krhovska, Tomas Pika, Jaroslav Bacovsky, Sabina Sevcikova, RNDr, PhD, Jakub Radocha, MD PhD, Vlastimil Scudla, Prof, MD CSc, Roman Hájek, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5414.
https://doi.org/10.1182/blood.V130.Suppl_1.5414.5414
Published: 2017
Journal Articles

"Real World" Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Combined Study from the Greek, Czech and UK Databases

Evangelos Terpos, MD PhD, Nadjoua Maouche, Jiri Minarik, MD PhD, Eirini Katodritou, Matthew W Jenner, Hana Plonkova, Maria Gavriatopoulou, Grant Vallance, Tomas Pika, Maria Kotsopoulou, Jaimal Kothari, Tomas Jelinek, Eftathios Kastritis, Robin Aitchison, Meletios A. Dimopoulos, Karthik Ramasamy, Roman Hajek
Journal: Blood
Blood (2017) 130 (Supplement 1): 3087.
https://doi.org/10.1182/blood.V130.Suppl_1.3087.3087
Published: 2017